The global Echinocandins for Injection market was valued at US$ 891 million in 2023 and is anticipated to reach US$ 1167.5 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

Echinocandins for Injection Market

Echinocandins are a class of antifungal drugs that inhibit the synthesis of β-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-β glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria.

Echinocandins are a class of antifungal medications administered through injection, widely used to treat severe fungal infections. These drugs target the β-1,3-glucan synthase enzyme in the fungal cell wall, leading to the inhibition of cell wall synthesis and subsequent fungal cell death. Common echinocandins include caspofungin, anidulafungin, and micafungin, often utilized in the treatment of refractory candidiasis such as invasive candidiasis. They typically require strict medical supervision and judicious use due to their lower toxicity targeting fungal cell wall synthesis, making them an important choice in combating fungal infections.

This report aims to provide a comprehensive presentation of the global market for Echinocandins for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Echinocandins for Injection.

Report Scope

The Echinocandins for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Echinocandins for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Echinocandins for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Echinocandins for Injection Market Report

Report Metric	Details
Report Name	Echinocandins for Injection Market
Accounted market size in 2023	US$ 891 million
Forecasted market size in 2030	US$ 1167.5 million
CAGR	3.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Caspofungin Micafungin Anidulafungin
Segment by Application	Hospital Drugstore
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Astellas, Endo International, Xellia Pharmaceuticals, Teva, Hikma, Apotex, Fresenius, Pfizer, CTTQ, QILU Pharmaceutical, BrightGene Bio-Medical Technology, Hansoh Pharmaceutical, HISUN
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Echinocandins for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Echinocandins for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Echinocandins for Injection Market growing?

Ans: The Echinocandins for Injection Market witnessing a CAGR of 3.9% during the forecast period 2024-2030.

What is the Echinocandins for Injection Market size in 2030?

Ans: The Echinocandins for Injection Market size in 2030 will be US$ 1167.5 million.

Who are the main players in the Echinocandins for Injection Market report?

Ans: The main players in the Echinocandins for Injection Market are Merck, Astellas, Endo International, Xellia Pharmaceuticals, Teva, Hikma, Apotex, Fresenius, Pfizer, CTTQ, QILU Pharmaceutical, BrightGene Bio-Medical Technology, Hansoh Pharmaceutical, HISUN

What are the Application segmentation covered in the Echinocandins for Injection Market report?

Ans: The Applications covered in the Echinocandins for Injection Market report are Hospital, Drugstore

What are the Type segmentation covered in the Echinocandins for Injection Market report?

Ans: The Types covered in the Echinocandins for Injection Market report are Caspofungin, Micafungin, Anidulafungin

1 Echinocandins for Injection Market Overview

1.1 Product Overview and Scope of Echinocandins for Injection

1.2 Echinocandins for Injection Segment by Type

1.2.1 Global Echinocandins for Injection Market Value Comparison by Type (2024-2030)

1.2.2 Caspofungin

1.2.3 Micafungin

1.2.4 Anidulafungin

1.3 Echinocandins for Injection Segment by Application

1.3.1 Global Echinocandins for Injection Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Drugstore

1.4 Global Echinocandins for Injection Market Size Estimates and Forecasts

1.4.1 Global Echinocandins for Injection Revenue 2019-2030

1.4.2 Global Echinocandins for Injection Sales 2019-2030

1.4.3 Global Echinocandins for Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Echinocandins for Injection Market Competition by Manufacturers

2.1 Global Echinocandins for Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Echinocandins for Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Echinocandins for Injection Average Price by Manufacturers (2019-2024)

2.4 Global Echinocandins for Injection Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Echinocandins for Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Echinocandins for Injection, Product Type & Application

2.7 Echinocandins for Injection Market Competitive Situation and Trends

2.7.1 Echinocandins for Injection Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Echinocandins for Injection Players Market Share by Revenue

2.7.3 Global Echinocandins for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Echinocandins for Injection Retrospective Market Scenario by Region

3.1 Global Echinocandins for Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Echinocandins for Injection Global Echinocandins for Injection Sales by Region: 2019-2030

3.2.1 Global Echinocandins for Injection Sales by Region: 2019-2024

3.2.2 Global Echinocandins for Injection Sales by Region: 2025-2030

3.3 Global Echinocandins for Injection Global Echinocandins for Injection Revenue by Region: 2019-2030

3.3.1 Global Echinocandins for Injection Revenue by Region: 2019-2024

3.3.2 Global Echinocandins for Injection Revenue by Region: 2025-2030

3.4 North America Echinocandins for Injection Market Facts & Figures by Country

3.4.1 North America Echinocandins for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Echinocandins for Injection Sales by Country (2019-2030)

3.4.3 North America Echinocandins for Injection Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Echinocandins for Injection Market Facts & Figures by Country

3.5.1 Europe Echinocandins for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Echinocandins for Injection Sales by Country (2019-2030)

3.5.3 Europe Echinocandins for Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Echinocandins for Injection Market Facts & Figures by Country

3.6.1 Asia Pacific Echinocandins for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Echinocandins for Injection Sales by Country (2019-2030)

3.6.3 Asia Pacific Echinocandins for Injection Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Echinocandins for Injection Market Facts & Figures by Country

3.7.1 Latin America Echinocandins for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Echinocandins for Injection Sales by Country (2019-2030)

3.7.3 Latin America Echinocandins for Injection Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Echinocandins for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Echinocandins for Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Echinocandins for Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Echinocandins for Injection Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Echinocandins for Injection Sales by Type (2019-2030)

4.1.1 Global Echinocandins for Injection Sales by Type (2019-2024)

4.1.2 Global Echinocandins for Injection Sales by Type (2025-2030)

4.1.3 Global Echinocandins for Injection Sales Market Share by Type (2019-2030)

4.2 Global Echinocandins for Injection Revenue by Type (2019-2030)

4.2.1 Global Echinocandins for Injection Revenue by Type (2019-2024)

4.2.2 Global Echinocandins for Injection Revenue by Type (2025-2030)

4.2.3 Global Echinocandins for Injection Revenue Market Share by Type (2019-2030)

4.3 Global Echinocandins for Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Echinocandins for Injection Sales by Application (2019-2030)

5.1.1 Global Echinocandins for Injection Sales by Application (2019-2024)

5.1.2 Global Echinocandins for Injection Sales by Application (2025-2030)

5.1.3 Global Echinocandins for Injection Sales Market Share by Application (2019-2030)

5.2 Global Echinocandins for Injection Revenue by Application (2019-2030)

5.2.1 Global Echinocandins for Injection Revenue by Application (2019-2024)

5.2.2 Global Echinocandins for Injection Revenue by Application (2025-2030)

5.2.3 Global Echinocandins for Injection Revenue Market Share by Application (2019-2030)

5.3 Global Echinocandins for Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Echinocandins for Injection Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Astellas

6.2.1 Astellas Corporation Information

6.2.2 Astellas Description and Business Overview

6.2.3 Astellas Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Astellas Echinocandins for Injection Product Portfolio

6.2.5 Astellas Recent Developments/Updates

6.3 Endo International

6.3.1 Endo International Corporation Information

6.3.2 Endo International Description and Business Overview

6.3.3 Endo International Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Endo International Echinocandins for Injection Product Portfolio

6.3.5 Endo International Recent Developments/Updates

6.4 Xellia Pharmaceuticals

6.4.1 Xellia Pharmaceuticals Corporation Information

6.4.2 Xellia Pharmaceuticals Description and Business Overview

6.4.3 Xellia Pharmaceuticals Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Xellia Pharmaceuticals Echinocandins for Injection Product Portfolio

6.4.5 Xellia Pharmaceuticals Recent Developments/Updates

6.5 Teva

6.5.1 Teva Corporation Information

6.5.2 Teva Description and Business Overview

6.5.3 Teva Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Teva Echinocandins for Injection Product Portfolio

6.5.5 Teva Recent Developments/Updates

6.6 Hikma

6.6.1 Hikma Corporation Information

6.6.2 Hikma Description and Business Overview

6.6.3 Hikma Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hikma Echinocandins for Injection Product Portfolio

6.6.5 Hikma Recent Developments/Updates

6.7 Apotex

6.6.1 Apotex Corporation Information

6.6.2 Apotex Description and Business Overview

6.6.3 Apotex Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Apotex Echinocandins for Injection Product Portfolio

6.7.5 Apotex Recent Developments/Updates

6.8 Fresenius

6.8.1 Fresenius Corporation Information

6.8.2 Fresenius Description and Business Overview

6.8.3 Fresenius Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Fresenius Echinocandins for Injection Product Portfolio

6.8.5 Fresenius Recent Developments/Updates

6.9 Pfizer

6.9.1 Pfizer Corporation Information

6.9.2 Pfizer Description and Business Overview

6.9.3 Pfizer Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Pfizer Echinocandins for Injection Product Portfolio

6.9.5 Pfizer Recent Developments/Updates

6.10 CTTQ

6.10.1 CTTQ Corporation Information

6.10.2 CTTQ Description and Business Overview

6.10.3 CTTQ Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.10.4 CTTQ Echinocandins for Injection Product Portfolio

6.10.5 CTTQ Recent Developments/Updates

6.11 QILU Pharmaceutical

6.11.1 QILU Pharmaceutical Corporation Information

6.11.2 QILU Pharmaceutical Echinocandins for Injection Description and Business Overview

6.11.3 QILU Pharmaceutical Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.11.4 QILU Pharmaceutical Echinocandins for Injection Product Portfolio

6.11.5 QILU Pharmaceutical Recent Developments/Updates

6.12 BrightGene Bio-Medical Technology

6.12.1 BrightGene Bio-Medical Technology Corporation Information

6.12.2 BrightGene Bio-Medical Technology Echinocandins for Injection Description and Business Overview

6.12.3 BrightGene Bio-Medical Technology Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.12.4 BrightGene Bio-Medical Technology Echinocandins for Injection Product Portfolio

6.12.5 BrightGene Bio-Medical Technology Recent Developments/Updates

6.13 Hansoh Pharmaceutical

6.13.1 Hansoh Pharmaceutical Corporation Information

6.13.2 Hansoh Pharmaceutical Echinocandins for Injection Description and Business Overview

6.13.3 Hansoh Pharmaceutical Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Hansoh Pharmaceutical Echinocandins for Injection Product Portfolio

6.13.5 Hansoh Pharmaceutical Recent Developments/Updates

6.14 HISUN

6.14.1 HISUN Corporation Information

6.14.2 HISUN Echinocandins for Injection Description and Business Overview

6.14.3 HISUN Echinocandins for Injection Sales, Revenue and Gross Margin (2019-2024)

6.14.4 HISUN Echinocandins for Injection Product Portfolio

6.14.5 HISUN Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Echinocandins for Injection Industry Chain Analysis

7.2 Echinocandins for Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Echinocandins for Injection Production Mode & Process

7.4 Echinocandins for Injection Sales and Marketing

7.4.1 Echinocandins for Injection Sales Channels

7.4.2 Echinocandins for Injection Distributors

7.5 Echinocandins for Injection Customers

8 Echinocandins for Injection Market Dynamics

8.1 Echinocandins for Injection Industry Trends

8.2 Echinocandins for Injection Market Drivers

8.3 Echinocandins for Injection Market Challenges

8.4 Echinocandins for Injection Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Astellas

Endo International

Xellia Pharmaceuticals

BrightGene Bio-Medical Technology

Hansoh Pharmaceutical

HISUN

List of Tables

Table 1. Global Echinocandins for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Echinocandins for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Echinocandins for Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Echinocandins for Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Echinocandins for Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Echinocandins for Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Echinocandins for Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Echinocandins for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Echinocandins for Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Echinocandins for Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Echinocandins for Injection, Product Type & Application

Table 12. Global Key Manufacturers of Echinocandins for Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Echinocandins for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Echinocandins for Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Echinocandins for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Echinocandins for Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global Echinocandins for Injection Sales Market Share by Region (2019-2024)

Table 19. Global Echinocandins for Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global Echinocandins for Injection Sales Market Share by Region (2025-2030)

Table 21. Global Echinocandins for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Echinocandins for Injection Revenue Market Share by Region (2019-2024)

Table 23. Global Echinocandins for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Echinocandins for Injection Revenue Market Share by Region (2025-2030)

Table 25. North America Echinocandins for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Echinocandins for Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America Echinocandins for Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America Echinocandins for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Echinocandins for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Echinocandins for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Echinocandins for Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Echinocandins for Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Echinocandins for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Echinocandins for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Echinocandins for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Echinocandins for Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Echinocandins for Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Echinocandins for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Echinocandins for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Echinocandins for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Echinocandins for Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Echinocandins for Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Echinocandins for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Echinocandins for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Echinocandins for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Echinocandins for Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Echinocandins for Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Echinocandins for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Echinocandins for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Echinocandins for Injection Sales (K Units) by Type (2019-2024)

Table 51. Global Echinocandins for Injection Sales (K Units) by Type (2025-2030)

Table 52. Global Echinocandins for Injection Sales Market Share by Type (2019-2024)

Table 53. Global Echinocandins for Injection Sales Market Share by Type (2025-2030)

Table 54. Global Echinocandins for Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Echinocandins for Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Echinocandins for Injection Revenue Market Share by Type (2019-2024)

Table 57. Global Echinocandins for Injection Revenue Market Share by Type (2025-2030)

Table 58. Global Echinocandins for Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Echinocandins for Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Echinocandins for Injection Sales (K Units) by Application (2019-2024)

Table 61. Global Echinocandins for Injection Sales (K Units) by Application (2025-2030)

Table 62. Global Echinocandins for Injection Sales Market Share by Application (2019-2024)

Table 63. Global Echinocandins for Injection Sales Market Share by Application (2025-2030)

Table 64. Global Echinocandins for Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Echinocandins for Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Echinocandins for Injection Revenue Market Share by Application (2019-2024)

Table 67. Global Echinocandins for Injection Revenue Market Share by Application (2025-2030)

Table 68. Global Echinocandins for Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Echinocandins for Injection Price (US$/Unit) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Merck Echinocandins for Injection Product

Table 74. Merck Recent Developments/Updates

Table 75. Astellas Corporation Information

Table 76. Astellas Description and Business Overview

Table 77. Astellas Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Astellas Echinocandins for Injection Product

Table 79. Astellas Recent Developments/Updates

Table 80. Endo International Corporation Information

Table 81. Endo International Description and Business Overview

Table 82. Endo International Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Endo International Echinocandins for Injection Product

Table 84. Endo International Recent Developments/Updates

Table 85. Xellia Pharmaceuticals Corporation Information

Table 86. Xellia Pharmaceuticals Description and Business Overview

Table 87. Xellia Pharmaceuticals Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Xellia Pharmaceuticals Echinocandins for Injection Product

Table 89. Xellia Pharmaceuticals Recent Developments/Updates

Table 90. Teva Corporation Information

Table 91. Teva Description and Business Overview

Table 92. Teva Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Teva Echinocandins for Injection Product

Table 94. Teva Recent Developments/Updates

Table 95. Hikma Corporation Information

Table 96. Hikma Description and Business Overview

Table 97. Hikma Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Hikma Echinocandins for Injection Product

Table 99. Hikma Recent Developments/Updates

Table 100. Apotex Corporation Information

Table 101. Apotex Description and Business Overview

Table 102. Apotex Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Apotex Echinocandins for Injection Product

Table 104. Apotex Recent Developments/Updates

Table 105. Fresenius Corporation Information

Table 106. Fresenius Description and Business Overview

Table 107. Fresenius Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Fresenius Echinocandins for Injection Product

Table 109. Fresenius Recent Developments/Updates

Table 110. Pfizer Corporation Information

Table 111. Pfizer Description and Business Overview

Table 112. Pfizer Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Pfizer Echinocandins for Injection Product

Table 114. Pfizer Recent Developments/Updates

Table 115. CTTQ Corporation Information

Table 116. CTTQ Description and Business Overview

Table 117. CTTQ Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. CTTQ Echinocandins for Injection Product

Table 119. CTTQ Recent Developments/Updates

Table 120. QILU Pharmaceutical Corporation Information

Table 121. QILU Pharmaceutical Description and Business Overview

Table 122. QILU Pharmaceutical Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. QILU Pharmaceutical Echinocandins for Injection Product

Table 124. QILU Pharmaceutical Recent Developments/Updates

Table 125. BrightGene Bio-Medical Technology Corporation Information

Table 126. BrightGene Bio-Medical Technology Description and Business Overview

Table 127. BrightGene Bio-Medical Technology Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. BrightGene Bio-Medical Technology Echinocandins for Injection Product

Table 129. BrightGene Bio-Medical Technology Recent Developments/Updates

Table 130. Hansoh Pharmaceutical Corporation Information

Table 131. Hansoh Pharmaceutical Description and Business Overview

Table 132. Hansoh Pharmaceutical Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Hansoh Pharmaceutical Echinocandins for Injection Product

Table 134. Hansoh Pharmaceutical Recent Developments/Updates

Table 135. HISUN Corporation Information

Table 136. HISUN Description and Business Overview

Table 137. HISUN Echinocandins for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. HISUN Echinocandins for Injection Product

Table 139. HISUN Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Echinocandins for Injection Distributors List

Table 143. Echinocandins for Injection Customers List

Table 144. Echinocandins for Injection Market Trends

Table 145. Echinocandins for Injection Market Drivers

Table 146. Echinocandins for Injection Market Challenges

Table 147. Echinocandins for Injection Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Echinocandins for Injection

Figure 2. Global Echinocandins for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Echinocandins for Injection Market Share by Type in 2023 & 2030

Figure 4. Caspofungin Product Picture

Figure 5. Micafungin Product Picture

Figure 6. Anidulafungin Product Picture

Figure 7. Global Echinocandins for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Echinocandins for Injection Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Drugstore

Figure 11. Global Echinocandins for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Echinocandins for Injection Market Size (2019-2030) & (US$ Million)

Figure 13. Global Echinocandins for Injection Sales (2019-2030) & (K Units)

Figure 14. Global Echinocandins for Injection Average Price (US$/Unit) & (2019-2030)

Figure 15. Echinocandins for Injection Report Years Considered

Figure 16. Echinocandins for Injection Sales Share by Manufacturers in 2023

Figure 17. Global Echinocandins for Injection Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Echinocandins for Injection Players: Market Share by Revenue in 2023

Figure 19. Echinocandins for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Echinocandins for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Echinocandins for Injection Sales Market Share by Country (2019-2030)

Figure 22. North America Echinocandins for Injection Revenue Market Share by Country (2019-2030)

Figure 23. United States Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Echinocandins for Injection Sales Market Share by Country (2019-2030)

Figure 26. Europe Echinocandins for Injection Revenue Market Share by Country (2019-2030)

Figure 27. Germany Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Echinocandins for Injection Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Echinocandins for Injection Revenue Market Share by Region (2019-2030)

Figure 34. China Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Echinocandins for Injection Sales Market Share by Country (2019-2030)

Figure 42. Latin America Echinocandins for Injection Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Echinocandins for Injection Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Echinocandins for Injection Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Echinocandins for Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Echinocandins for Injection by Type (2019-2030)

Figure 52. Global Revenue Market Share of Echinocandins for Injection by Type (2019-2030)

Figure 53. Global Echinocandins for Injection Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Echinocandins for Injection by Application (2019-2030)

Figure 55. Global Revenue Market Share of Echinocandins for Injection by Application (2019-2030)

Figure 56. Global Echinocandins for Injection Price (US$/Unit) by Application (2019-2030)

Figure 57. Echinocandins for Injection Value Chain

Figure 58. Echinocandins for Injection Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Carprofen Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-28L13471

Thu Oct 03 00:00:00 UTC 2024

Add to Cart

Global Pet NSAIDs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13C13860

Thu Oct 03 00:00:00 UTC 2024

Add to Cart

Global Echinocandins for Injection Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29S16047

Thu Oct 03 00:00:00 UTC 2024

Add to Cart

Global Percutaneous Nephrolithotomy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33C15574

Thu Oct 03 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions